Postherpetic Neuralgia
📧 Sign up to get email alerts when something new happens for Postherpetic Neuralgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-12-15FDA Approved: CARBAMAZEPINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Carbamazepine (generic) submitted by Chartwell RX, LLC.
-
FDA approval · 2009-11-20FDA Approved: GABAPENTIN — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for gabapentin from BluePoint Laboratories, granting approval to market a generic gabapentin product…
-
FDA approval · 2009-11-16FDA Approved: QUTENZA — Original Application (Averitas Pharma Inc)
FDA approved QUTENZA (capsaicin) 8% patch from Averitas Pharma Inc in its original application for the treatment of postherpetic neuralgia.
-
CLINICAL_TRIALS trial_result · 2009-09-28Clinical Trial Update: A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia [Phase 3]
Phase 3 long-term study evaluating pregabalin for postherpetic neuralgia completed; results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-09-11Clinical Trial Update: Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia [Phase 2]
Phase 2 study evaluating the bupivacaine patch Eladur for postherpetic neuralgia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-09-09Clinical Trial Update: Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN) [Phase 2]
A Phase 2 trial evaluating NGX-4010 with open-label lidocaine/prilocaine cream for postherpetic neuralgia has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP [Phase 4]
Phase 4 clinical trial update of pregabalin for peripheral neuropathic pain conditions including diabetic peripheral neuropathic pain and po…
-
CLINICAL_TRIALS trial_result · 2009-07-30Clinical Trial Update: Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of SLC022 for pain associated with postherpetic neuralgia. The current status of t…
-
CLINICAL_TRIALS trial_result · 2009-02-27Clinical Trial Update: A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia [Phase 3]
A Phase 3 randomized, double-blind trial evaluated pregabalin for postherpetic neuralgia; results were posted after completion in 2009.
-
CLINICAL_TRIALS research · 2008-10-07Clinical Trial Update: Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles) [Phase 2]
Phase 2 trial evaluating ARYS-01 cream 3% (sorivudine), oral valaciclovir, and their combination for treatment of herpes zoster and preventi…
-
CLINICAL_TRIALS trial_result · 2008-07-22Clinical Trial Update: A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN) [Phase 2]
A Phase 2 clinical trial evaluated topical KD7040 for postherpetic neuralgia and has completed. The update does not include efficacy or safe…
-
CLINICAL_TRIALS trial_result · 2008-03-06Clinical Trial Update: NGX-4010 for the Treatment of Postherpetic Neuralgia [Phase 2, Phase 3]
Phase 2 and Phase 3 trials of NGX-4010 (capsaicin patch 8%) for postherpetic neuralgia have completed, with status indicating completion of …
-
CLINICAL_TRIALS trial_result · 2008-03-06Clinical Trial Update: Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN) [Phase 2]
A Phase 2 study evaluating NGX-4010 for painful HIV-associated neuropathy and postherpetic neuralgia has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-06Clinical Trial Update: Study of NGX-4010 for the Treatment of Postherpetic Neuralgia [Phase 3]
Phase 3 study of NGX-4010 for postherpetic neuralgia has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-06Clinical Trial Update: Study of NGX-4010 for the Treatment of Postherpetic Neuralgia [Phase 3]
Phase 3 study of NGX-4010 for postherpetic neuralgia has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-06Clinical Trial Update: Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia [Phase 3]
This update reports the completion of a Phase 3 controlled trial evaluating NGX-4010 for postherpetic neuralgia.
-
CLINICAL_TRIALS trial_result · 2008-01-11Clinical Trial Update: Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain [Phase 2]
A Phase 2 trial update reports tolerability findings for three local anesthetic formulations used with NGX-4010 (capsaicin 8% patch) in the …
-
CLINICAL_TRIALS trial_result · 2007-11-08Clinical Trial Update: [S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain. [Phase 2]
Pfizer-sponsored Phase 2 long-term safety study of S,S-Reboxetine in postherpetic neuralgia has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-08-02Clinical Trial Update: Safety and Efficacy of Gabapentin in Postherpetic Neuralgia [Phase 3]
Phase 3 study of gabapentin for postherpetic neuralgia has completed. The update reports on safety and efficacy.
-
FDA approval · 2007-07-25FDA Approved: GABAPENTIN — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's original ANDA for gabapentin, providing a generic version of the anti-epileptic medication. Th…
-
FDA approval · 2007-06-21FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis (Pfizer) to update the labeling with expanded o…
-
CLINICAL_TRIALS trial_result · 2007-03-28Clinical Trial Update: Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia [Phase 2]
A Phase 2 placebo-controlled dose-response trial of PD-217,014 for postherpetic neuralgia has been terminated.
-
CLINICAL_TRIALS trial_result · 2006-12-22Clinical Trial Update: To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia. [Phase 3]
This phase 3 clinical trial reports long-term safety and efficacy data for pregabalin in patients with postherpetic neuralgia.
-
FDA label_change · 2006-12-07FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)
FDA approved a supplemental application for gabapentin—specifically a granule formulation—from Granules Pharmaceuticals Inc.
-
FDA approval · 2006-12-05FDA Approved: GABAPENTIN — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma's supplemental application for gabapentin as a generic drug under ANDA 075350.